South Koreans' favorite beverage on Hollys Coffee’s menu in January, the coldest month in the country, turned out to be Iced Americano.
Sales statistics in January collected from customers with a Hollys membership, revealed that iced Americanos make up 55 percent of total Americano sales.
Iced Americanos rank first among those in their 10s, 20s, and 30s, and were a second and third place, respectively, among those in their 40s and 50s.
The average temperature in South Korea was below zero in January.
On Jan. 25, 46 percent of Americano drinkers grabbed a cold one while alow of minus 17.3 degrees Celsius and an average of minus 11.3 degrees Celsius were recorded during the Siberian cold wave.
The percentage went close to 60 percent on Jan. 21, the second-coldest day of the month with a low of minus 10.5 C.
According to Hollys Coffee, one of South Korea’s top 10 coffee franchises, Koreans seem to love iced Americanos as itsuits their taste and is easy to drink quickly.


Moderna Stock Drops After FDA Declines Review of mRNA Flu Vaccine
TrumpRx.gov Highlights GLP-1 Drug Discounts but Offers Limited Savings for Most Americans
Why have so few atrocities ever been recognised as genocide?
Innate Pharma Reports 55% Revenue Drop and €49.2M Net Loss for 2025
OpenAI Pulls the Plug on Sora, Ending $1 Billion Disney Partnership
What’s the difference between baking powder and baking soda? It’s subtle, but significant
Valero Port Arthur Refinery Explosion Prompts $1M Lawsuit Over Worker Safety Negligence
Asian Markets Rally as Oil Prices Tumble and Middle East Peace Hopes Emerge
Vanda Pharmaceuticals (VNDA) Stock Soars After FDA Approves BYSANTI for Bipolar I and Schizophrenia
Trump Tariffs Show Minimal Economic Impact but Boost Federal Revenue, Study Finds
NAB Plans to Cut 170 Jobs While Expanding Offshore Operations
Merck's $6 Billion Bid for Terns Pharma Signals Bold Oncology Push
Merck Raises Growth Outlook, Targets $70 Billion Revenue From New Drugs by Mid-2030s
Sonova Shares Slip as Hearing Aid Giant Lowers Growth Outlook and Plans Sennheiser Exit
Japan Eyes Oil Futures Intervention to Stabilize Yen Amid Middle East Crisis
Novartis’ Vanrafia Shows Strong Phase 3 Results in IgA Nephropathy, Paving Way for Full Approval 



